
Titan Biotech Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-20 08:03:35Titan Biotech Ltd, a micro-cap player in the Specialty Chemicals sector, has experienced a notable shift in its technical momentum, reflecting a nuanced market sentiment. Despite a recent downgrade from a Buy to a Hold rating by MarketsMOJO, the stock’s long-term returns remain impressive, though short-term price action signals caution.
Read MoreTitan Biotech Falls 18.45% Despite Record Highs: 4 Key Factors Driving the Decline
2026-04-11 15:06:04Key Events This Week 6 Apr: New 52-week and all-time high at Rs.529.15 7 Apr: Further 52-week and all-time high at Rs.555.65 8 Apr: Sharp decline begins with heavy volume 10 Apr: Week closes at Rs.431.55, down 18.45% Week OpenRs.529.20 Week CloseRs.431.55...
Read More
Titan Biotech Ltd is Rated Buy by MarketsMOJO
2026-04-11 10:10:48Titan Biotech Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 11 April 2026, providing investors with the most recent insights into its performance and outlook.
Read More
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 529.15
2026-04-06 09:41:15Surging past its previous peaks, Titan Biotech Ltd touched a fresh 52-week high of Rs 529.15 on 6 Apr 2026, marking a remarkable rally from its 52-week low of Rs 74.73. This milestone caps a seven-day winning streak that has propelled the stock up by 36.55%, underscoring a powerful momentum that stands out amid a broadly subdued market backdrop.
Read More
435.8% Stock Return, 20.9% Profit Growth: What’s Driving Titan Biotech Ltd’s Multibagger Rerating?
2026-04-02 11:30:05A 435.8% stock return in one year. A 20.9% growth in net profit over the same period. The gap between those two numbers — roughly 415 percentage points — is driven entirely by the market's willingness to pay more for each rupee of Titan Biotech Ltd's earnings. That willingness is the story.
Read More
Broad-Based Technical Strength Lifts Titan Biotech Ltd to 52-Week High of Rs 502.4
2026-04-02 09:46:24Surging from a 52-week low of Rs 74.73 to a fresh high of Rs 502.4 on 2 Apr 2026, Titan Biotech Ltd has delivered an extraordinary 403.68% return over the past year, defying the broader market’s downward trend. This milestone caps a remarkable rally fuelled by a confluence of strong technical indicators and sustained price momentum.
Read More
Titan Biotech Ltd Hits All-Time High of Rs 502.4 as Momentum Builds Across Timeframes
2026-04-02 09:30:50Extending its winning streak to six consecutive sessions, Titan Biotech Ltd surged to a fresh all-time high of Rs 502.4 on 2 Apr 2026, outperforming both its sector and the broader market by a wide margin.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
01-Jun-2026 | Source : BSENewspaper publication of the Audited Financial Results (Standalone & Consolidated) for fourth quarter and year ended March 31 2026
Board Meeting Outcome for Outcome Of The Board Meeting Of Titan Biotech Limited Held Today I.E. 30Th May 2026
30-May-2026 | Source : BSEPursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you that the Board of Directors at its meeting held today i.e. Saturday 30th May 2026 Approval of Audited Financial Results For The Fourth Quarter And Year Ended 31st March 2026 Recommendation of Dividend re appointment of Cost Auditor and Appointment of Scrutinizer
Re-Appointment Of Cost Auditor For Financial Year 2026-2027
30-May-2026 | Source : BSEIntimation for re-appointment of Cost Auditor of the Company
Corporate Actions
No Upcoming Board Meetings
Titan Biotech Ltd has declared 20% dividend, ex-date: 19 Sep 25
Titan Biotech Ltd has announced 2:10 stock split, ex-date: 20 Feb 26
No Bonus history available
No Rights history available

